Free tool
FAERS Monitor: Nipride Rtu In Sodium Chloride 0.9%
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209387 or its brand name (Nipride Rtu In Sodium Chloride 0.9%, Sodium Nitroprusside). Reports on generic versions are filed under their own applications.
Reports
387
Serious
360
93% of reports
Hospitalization
175
Death reported
85
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- renal failure74
- pain62
- injury59
- anxiety58
- unevaluable event55
- drug ineffective53
- fear53
- toxicity to various agents49
- renal injury44
- emotional distress43
- anhedonia41
- renal impairment38
- stress38
- hypotension34
- multi-organ failure32
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 6 |
| 2006 | 10 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 8 |
| 2010 | 10 |
| 2011 | 75 |
| 2012 | 9 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 16 |
| 2016 | 8 |
| 2017 | 15 |
| 2018 | 11 |
| 2019 | 20 |
| 2020 | 19 |
| 2021 | 29 |
| 2022 | 27 |
| 2023 | 27 |
| 2024 | 31 |
| 2025 | 19 |
| 2026 | 23 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,772 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| fearSignal | 53 | 107.3 | 83.5 | 5,472 |
| multi-organ failureSignal | 32 | 100.7 | 72.2 | 3,057 |
| anhedoniaSignal | 41 | 84.9 | 63.6 | 3,316 |
| renal injurySignal | 44 | 80.6 | 61.0 | 3,380 |
| injurySignal | 59 | 45.6 | 36.1 | 2,538 |
| unevaluable eventSignal | 55 | 39.5 | 31.0 | 2,033 |
| renal failureSignal | 74 | 30.3 | 24.7 | 2,080 |
| stressSignal | 38 | 28.7 | 21.2 | 990 |
| renal impairmentSignal | 38 | 24.6 | 18.2 | 840 |
| emotional distressSignal | 43 | 19.3 | 14.6 | 732 |
| toxicity to various agentsSignal | 49 | 15.8 | 12.2 | 670 |
| anxietySignal | 58 | 11.1 | 8.7 | 529 |
| hypotensionSignal | 34 | 9.2 | 6.7 | 243 |
| painSignal | 62 | 5.5 | 4.4 | 230 |
| drug ineffectiveSignal | 53 | 2.2 | 1.7 | 35 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.